These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 20395524)

  • 41. The florid subtype of lobular carcinoma in situ: marker or precursor for invasive lobular carcinoma?
    Bagaria SP; Shamonki J; Kinnaird M; Ray PS; Giuliano AE
    Ann Surg Oncol; 2011 Jul; 18(7):1845-51. PubMed ID: 21287281
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lobular carcinoma in situ on core biopsy-what is the clinical significance?
    O'Driscoll D; Britton P; Bobrow L; Wishart GC; Sinnatamby R; Warren R
    Clin Radiol; 2001 Mar; 56(3):216-20. PubMed ID: 11247699
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Assessment of pathologic prognostic factors in breast core needle biopsies.
    Sharifi S; Peterson MK; Baum JK; Raza S; Schnitt SJ
    Mod Pathol; 1999 Oct; 12(10):941-5. PubMed ID: 10530557
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lobular in-situ neoplasia on breast core needle biopsy: imaging indication and pathologic extent can identify which patients require excisional biopsy.
    Rendi MH; Dintzis SM; Lehman CD; Calhoun KE; Allison KH
    Ann Surg Oncol; 2012 Mar; 19(3):914-21. PubMed ID: 21861212
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Classic lobular carcinoma in situ and atypical lobular hyperplasia at percutaneous breast core biopsy: outcomes of prospective excision.
    Murray MP; Luedtke C; Liberman L; Nehhozina T; Akram M; Brogi E
    Cancer; 2013 Mar; 119(5):1073-9. PubMed ID: 23132235
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Significance of flat epithelial atypia on mammotome core needle biopsy: Should it be excised?
    Kunju LP; Kleer CG
    Hum Pathol; 2007 Jan; 38(1):35-41. PubMed ID: 17095049
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Lobular carcinoma in situ (LCIS): risk factor and precursor of invasive lobular breast cancer].
    Aulmann S; Penzel R; Schirmacher P; Sinn HP
    Verh Dtsch Ges Pathol; 2007; 91():208-13. PubMed ID: 18314616
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Accuracy of a preoperative model for predicting invasive breast cancer in women with ductal carcinoma-in-situ on vacuum-assisted core needle biopsy.
    Houssami N; Ambrogetti D; Marinovich ML; Bianchi S; Macaskill P; Vezzosi V; Mamounas EP; Ciatto S
    Ann Surg Oncol; 2011 May; 18(5):1364-71. PubMed ID: 21107741
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Epidemiological survey of preinvasive breast cancer.
    Vandenbroucke A; Bourdon C
    Eur J Cancer Prev; 1993 Nov; 2 Suppl 3():3-10. PubMed ID: 8298449
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Histologic grading at breast core needle biopsy: comparison with results from the excised breast specimen.
    Monticciolo DL
    Breast J; 2005; 11(1):9-14. PubMed ID: 15647072
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [A follow-up study about 52 cases of atypical lobular hyperplasia and lobular carcinoma in situ of the breast].
    Li HY; Ren GS; Arnould N; Brettes JP
    Zhonghua Wai Ke Za Zhi; 2007 Jul; 45(13):874-6. PubMed ID: 17953828
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Papillomas and atypical papillomas in breast core needle biopsy specimens: risk of carcinoma in subsequent excision.
    Renshaw AA; Derhagopian RP; Tizol-Blanco DM; Gould EW
    Am J Clin Pathol; 2004 Aug; 122(2):217-21. PubMed ID: 15323138
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Predictors of residual invasive disease after core needle biopsy diagnosis of ductal carcinoma in situ.
    Rutstein LA; Johnson RR; Poller WR; Dabbs D; Groblewski J; Rakitt T; Tsung A; Kirchner T; Sumkin J; Keenan D; Soran A; Ahrendt G; Falk JS
    Breast J; 2007; 13(3):251-7. PubMed ID: 17461899
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clonality of lobular carcinoma in situ (LCIS) and metachronous invasive breast cancer.
    Aulmann S; Penzel R; Longerich T; Funke B; Schirmacher P; Sinn HP
    Breast Cancer Res Treat; 2008 Feb; 107(3):331-5. PubMed ID: 17380381
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Carcinoma in situ of the breast].
    Laenkholm AV; Hoffmann J; Rank FE
    Ugeskr Laeger; 2007 Sep; 169(37):3087-90. PubMed ID: 17877955
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Extent and histologic pattern of atypical ductal hyperplasia present on core needle biopsy specimens of the breast can predict ductal carcinoma in situ in subsequent excision.
    Wagoner MJ; Laronga C; Acs G
    Am J Clin Pathol; 2009 Jan; 131(1):112-21. PubMed ID: 19095574
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Incidental finding of mammary carcinoma in lumpectomy specimens.
    Tang P; Hajdu SI; Conte CC; Filardi DA
    Ann Clin Lab Sci; 2003; 33(1):23-31. PubMed ID: 12661895
    [TBL] [Abstract][Full Text] [Related]  

  • 58. LCIS found at core needle biopsy may not need surgical excision.
    Kopans DB
    AJR Am J Roentgenol; 2008 Sep; 191(3):W152; author reply W153. PubMed ID: 18716082
    [No Abstract]   [Full Text] [Related]  

  • 59. Lobular carcinoma in situ variants in breast cores: potential for misdiagnosis, upgrade rates at surgical excision, and practical implications.
    Sullivan ME; Khan SA; Sullu Y; Schiller C; Susnik B
    Arch Pathol Lab Med; 2010 Jul; 134(7):1024-8. PubMed ID: 20586632
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lobular intraepithelial neoplasia [lobular carcinoma in situ] with comedo-type necrosis: A clinicopathologic study of 18 cases.
    Fadare O; Dadmanesh F; Alvarado-Cabrero I; Snyder R; Stephen Mitchell J; Tot T; Wang SA; Ghofrani M; Eusebi V; Martel M; Tavassoli FA
    Am J Surg Pathol; 2006 Nov; 30(11):1445-53. PubMed ID: 17063087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.